Top Markets
#1 Islamic Coin Islamic Coin +152.22%
#2 Bitway Bitway +67.08%
#3 Starpower Starpower +34.74%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +28.76%
#5 aelf aelf +26.48%
#6 Pons Pons +16.47%
#7 Decred Decred +14.39%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
#9 Ribbita by Virtuals Ribbita by Virtuals +13.52%
#10 DAPPOS DAPPOS +10.73%
Coin of the day
Islamic Coin Islamic Coin
設定
言語
日本
通貨
USD
テーマ
Malachite Innovations, Inc. Malachite Innovations, Inc.

Malachite Innovations, Inc.

MLCT
株式のランク #29801
Malachite Innovations, Inc., established in Cleveland, Ohio, in 2007, pursues a... Malachite Innovations, Inc., established in Cleveland, Ohio, in 2007, pursues a dual business strategy. Operating through its subsidiaries, the company delivers health and wellness products across the United States, featuring a comprehensive collection of nearly 100 innovative cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The firm is also advancing the development of THC-glycoside (VBX-100), an oral prodrug intended for treating gastrointestinal conditions such as inflammatory bowel disease and irritable bowel syndrome. Additionally, Malachite Innovations dedicates efforts to identifying, funding, and revitalizing environmental ventures, prioritizing advanced technology and sustainable practices. The company adopted its current name in October 2021, having previously operated as Vitality Biopharma, Inc.
株価
$0.38
最終同期: 2024-01-12
時価総額
$19.55M
変化（1日）
-1.30%
変化（1年）
0.00%
国
US
取引 Malachite Innovations, Inc. (MLCT)

カテゴリー

Healthcare
Malachite Innovations, Inc.（MLCT）の収益
Aug 2026 時点の収益 TTM: 0
Malachite Innovations, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Malachite Innovations, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR